Value Hunters: Look To Beam Therapeutics Inc (BEAM)
Currently, there are 99.84M common shares owned by the public and among those 88.04M shares have been available to trade. The company’s stock has a 5-day price change of -24.05% and -33.68% over the past three months. BEAM shares are trading -28.89% year to date (YTD), with the 12-month market performance down to -46.63% lower. […]
Gains May Be On The Menu For Beam Therapeutics Inc (NASDAQ: BEAM)
Currently, there are 83.63M common shares owned by the public and among those 73.69M shares have been available to trade. The company’s stock has a 5-day price change of 2.35% and -1.27% over the past three months. BEAM shares are trading 3.59% year to date (YTD), with the 12-month market performance down to -32.89% lower. […]
Reviewing The Case For Beam Therapeutics Inc (BEAM) Going Higher
ARK Investment Management LLC recently announced the acquisition of new stake in Beam Therapeutics Inc (NASDAQ:BEAM). The institutional investor has increased its shareholding in the Healthcare company by 6.94% to 9.39 million shares with purchase of 0.61 million shares. This fresh investment now brings its stake to 11.53% valued currently at $255.7 million. In addition, […]
Beam Therapeutics Inc (NASDAQ: BEAM) Not A Good Play Anymore?
ARK Investment Management LLC has recently announced that it has increased stake in Beam Therapeutics Inc (NASDAQ:BEAM) by 4.79%. After grabbing 8.78 million shares, the institutional investor is now in possession of 0.4 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 10.78% having worth around $246.65 million. […]
